Overcoming Drug Resistance—Nanoparticles Trigger Built-In Cell-Death Signal
Friday, June 13, 2008 - 13:21
in Health & Medicine
One of the most vexing problems in treating cancer is the propensity of tumors to develop resistance to a wide range of anticancer drugs. Over 70 percent of ovarian cancer patients, for example, have drug-resistant tumors at the time of their initial diagnosis, and virtually all patients who relapse have drug-resistant tumors.